FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004161162> ?p ?o ?g. }

• W2004161162 endingPage "1661" @default.
• W2004161162 startingPage "1661" @default.
• W2004161162 abstract "Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients Chuan Zou,1 Xiang Ding,1 Joseph H Flaherty,2 Birong Dong1 1The Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, People&#39;s Republic of China; 2St Louis University, St Louis, MO, USA Background: Generalized anxiety disorder (GAD) is a prevalent, disabling disease and is highly comorbid with other psychiatric disorders both in Western countries and the People&#39;s Republic of China. Fluoxetine, a selective inhibitor of serotonin reuptake (SSRI), is widely utilized in the management of GAD in clinical practice despite the lack of strong evidence. This article reviews fluoxetine trials to investigate fluoxetine&#39;s efficacy and tolerability in Chinese patients with GAD. Methods: A literature review was conducted using the following databases up to and including April 2013: Chinese BioMedical Literature, China National Knowledge Infrastructure, EMBASE, MEDLINE, and PsycINFO. We selected clinical studies that utilized fluoxetine for GAD in which all participants were Chinese. Results: Fifteen open-label, non-placebo trials were identified and analyzed; eleven anxiolytics were compared with fluoxetine separately. Short-term efficacy of fluoxetine had been established in these open-label, head-to-head controlled trials. Fluoxetine had rapid onset of action (approximately 1–2 weeks) and seemed to be effective in maintenance treatment. Fluoxetine was generally well-tolerated with the most common side effect of dry month and nausea. Compared to other anxiolytic agents, fluoxetine was equivalent with all of the comparative anxiolytics in terms of efficacy except mirtazapine which showed conflicting results with fluoxetine in two studies. In terms of side effects, fluoxetine was better tolerated than diazepam, doxepine, and amitriptyline, less tolerated than escitalopram, and had similar tolerability with duloxetine as well as alprazolam. Conclusion: Given the high risk of bias of the included studies, the overall small sample size of the studies, the lack of placebo control groups as well as the lack of certain clinically meaningful outcomes, it is not possible to recommend fluoxetine as a reliable first-line treatment in Chinese patients with GAD. Furthermore, no definitive implications for clinical practice in choosing anxiolytics can be drawn from this review. Trials with larger sample sizes, better quality, longer duration, and more clinically meaningful outcomes are needed in future research. Keywords: fluoxetine, generalized anxiety disorder, clinical trials, Chinese, prevalence" @default.
• W2004161162 created "2016-06-24" @default.
• W2004161162 creator A5007473761 @default.
• W2004161162 creator A5037242097 @default.
• W2004161162 creator A5068152983 @default.
• W2004161162 creator A5075368731 @default.
• W2004161162 date "2013-11-01" @default.
• W2004161162 modified "2023-10-18" @default.
• W2004161162 title "Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients" @default.
• W2004161162 cites W130896003 @default.
• W2004161162 cites W1598981490 @default.
• W2004161162 cites W1746481573 @default.
• W2004161162 cites W1966065460 @default.
• W2004161162 cites W1970407368 @default.
• W2004161162 cites W1974217639 @default.
• W2004161162 cites W1975122358 @default.
• W2004161162 cites W1982772915 @default.
• W2004161162 cites W1983201249 @default.
• W2004161162 cites W1999700628 @default.
• W2004161162 cites W2002863546 @default.
• W2004161162 cites W2003388617 @default.
• W2004161162 cites W2010919501 @default.
• W2004161162 cites W2018831144 @default.
• W2004161162 cites W2020198222 @default.
• W2004161162 cites W2022467221 @default.
• W2004161162 cites W2029379930 @default.
• W2004161162 cites W2031937662 @default.
• W2004161162 cites W2032747942 @default.
• W2004161162 cites W2035090322 @default.
• W2004161162 cites W2037875799 @default.
• W2004161162 cites W2043645215 @default.
• W2004161162 cites W2051486219 @default.
• W2004161162 cites W2054387447 @default.
• W2004161162 cites W2057286542 @default.
• W2004161162 cites W2057479214 @default.
• W2004161162 cites W2061469083 @default.
• W2004161162 cites W2067083885 @default.
• W2004161162 cites W2085940443 @default.
• W2004161162 cites W2086025676 @default.
• W2004161162 cites W2098867544 @default.
• W2004161162 cites W2114669966 @default.
• W2004161162 cites W2120148577 @default.
• W2004161162 cites W2127483997 @default.
• W2004161162 cites W2132227441 @default.
• W2004161162 cites W2135917232 @default.
• W2004161162 cites W2144269887 @default.
• W2004161162 cites W2149562154 @default.
• W2004161162 cites W2160500602 @default.
• W2004161162 cites W2162762176 @default.
• W2004161162 cites W2163006125 @default.
• W2004161162 cites W2205531850 @default.
• W2004161162 cites W2313763353 @default.
• W2004161162 cites W2354844746 @default.
• W2004161162 cites W2356840538 @default.
• W2004161162 cites W2358635507 @default.
• W2004161162 cites W2364805065 @default.
• W2004161162 cites W2366699584 @default.
• W2004161162 cites W2392363242 @default.
• W2004161162 cites W2394428612 @default.
• W2004161162 cites W2406704442 @default.
• W2004161162 cites W2606791358 @default.
• W2004161162 cites W3144478812 @default.
• W2004161162 cites W91596149 @default.
• W2004161162 doi "https://doi.org/10.2147/ndt.s38899" @default.
• W2004161162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3818099" @default.
• W2004161162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24204151" @default.
• W2004161162 hasPublicationYear "2013" @default.
• W2004161162 type Work @default.
• W2004161162 sameAs 2004161162 @default.
• W2004161162 citedByCount "10" @default.
• W2004161162 countsByYear W20041611622014 @default.
• W2004161162 countsByYear W20041611622015 @default.
• W2004161162 countsByYear W20041611622016 @default.
• W2004161162 countsByYear W20041611622017 @default.
• W2004161162 countsByYear W20041611622018 @default.
• W2004161162 countsByYear W20041611622019 @default.
• W2004161162 countsByYear W20041611622022 @default.
• W2004161162 crossrefType "journal-article" @default.
• W2004161162 hasAuthorship W2004161162A5007473761 @default.
• W2004161162 hasAuthorship W2004161162A5037242097 @default.
• W2004161162 hasAuthorship W2004161162A5068152983 @default.
• W2004161162 hasAuthorship W2004161162A5075368731 @default.
• W2004161162 hasBestOaLocation W20041611621 @default.
• W2004161162 hasConcept C118552586 @default.
• W2004161162 hasConcept C126322002 @default.
• W2004161162 hasConcept C142724271 @default.
• W2004161162 hasConcept C15744967 @default.
• W2004161162 hasConcept C170493617 @default.
• W2004161162 hasConcept C197934379 @default.
• W2004161162 hasConcept C204787440 @default.
• W2004161162 hasConcept C27081682 @default.
• W2004161162 hasConcept C2775864247 @default.
• W2004161162 hasConcept C2776134451 @default.
• W2004161162 hasConcept C2778375690 @default.
• W2004161162 hasConcept C2779177272 @default.
• W2004161162 hasConcept C2779911313 @default.
• W2004161162 hasConcept C2780092697 @default.
• W2004161162 hasConcept C2780580376 @default.

• next